Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Björn Regland

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Lakartidningen|July 12, 2017
[Vitamin B12/B9 – possible treatment for mental fatigue]Björn Regland
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 13, 2005
Schizophrenia and single-carbon metabolismBjörn Regland
Medical Hypotheses|March 3, 2021
COVID-19: A methyl-group assault?Andrew McCaddon, Björn Regland
Journal of Alzheimer'S Disease : JAD|March 1, 2019
Alzheimer's Amyloidopathy: An Alternative AspectBjörn Regland, Andrew McCaddon
Dementia and Geriatric Cognitive Disorders|June 27, 2003
Vitamin B12-B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairmentMartin Lehmann, Björn Regland, Kaj Blennow, et al.
Lakartidningen|June 21, 2003
[Sick listing--"disaster" or incompetence in statistics and diagnostics?]C G Gottfries, Björn Regland, Olof Zachrisson, et al.
Journal of Psychosomatic Research|June 19, 2002
A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale)Olof Zachrisson, Björn Regland, Marianne Jahreskog, et al.
European Journal of Pain (London, England)|November 5, 2002
Treatment with staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome--a randomised controlled trialOlof Zachrisson, Björn Regland, Marianne Jahreskog, et al.
Biological Psychiatry|February 1, 2003
Alzheimer's disease and total plasma aminothiolsAndrew McCaddon, Peter Hudson, Diane Hill, et al.
International Psychogeriatrics|July 30, 2005
The transcobalamin 776C > G polymorphism may be a modifiable genetic risk factor for Alzheimer's diseaseHenrik Zetterberg, Ebba Nexö, Lennart Minthon, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Lakartidningen|July 12, 2017
[Vitamin B12/B9 – possible treatment for mental fatigue]Björn Regland
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 13, 2005
Schizophrenia and single-carbon metabolismBjörn Regland
Medical Hypotheses|March 3, 2021
COVID-19: A methyl-group assault?Andrew McCaddon, Björn Regland
Journal of Alzheimer'S Disease : JAD|March 1, 2019
Alzheimer's Amyloidopathy: An Alternative AspectBjörn Regland, Andrew McCaddon
Dementia and Geriatric Cognitive Disorders|June 27, 2003
Vitamin B12-B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairmentMartin Lehmann, Björn Regland, Kaj Blennow, et al.
Lakartidningen|June 21, 2003
[Sick listing--"disaster" or incompetence in statistics and diagnostics?]C G Gottfries, Björn Regland, Olof Zachrisson, et al.
Journal of Psychosomatic Research|June 19, 2002
A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale)Olof Zachrisson, Björn Regland, Marianne Jahreskog, et al.
European Journal of Pain (London, England)|November 5, 2002
Treatment with staphylococcus toxoid in fibromyalgia/chronic fatigue syndrome--a randomised controlled trialOlof Zachrisson, Björn Regland, Marianne Jahreskog, et al.
Biological Psychiatry|February 1, 2003
Alzheimer's disease and total plasma aminothiolsAndrew McCaddon, Peter Hudson, Diane Hill, et al.
International Psychogeriatrics|July 30, 2005
The transcobalamin 776C > G polymorphism may be a modifiable genetic risk factor for Alzheimer's diseaseHenrik Zetterberg, Ebba Nexö, Lennart Minthon, et al.
Pageof 2